Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Hendifar

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
The American Journal of Dermatopathology|June 13, 2018
Primary Visceral Merkel Cell Carcinoma: A Case Report and Review of the LiteratureAndrew Siref, Andrew Hendifar, Bonnie Balzer
Drug Design, Development and Therapy|April 20, 2018
Aldoxorubicin: a tumor-targeted doxorubicin conjugate for relapsed or refractory soft tissue sarcomasJun Gong, Jessica Yan, Charles Forscher, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 27, 2018
The use of Ki-67 labeling index to grade pulmonary well-differentiated neuroendocrine neoplasms: current best evidenceAlberto M Marchevsky, Andrew Hendifar, Ann E Walts
Current Oncology Reports|March 19, 2022
Lung Neuroendocrine Tumors: How Does Molecular Profiling Help?Thomas Yang Sun, Andrew Hendifar, Sukhmani K Padda
Expert Review of Anticancer Therapy|June 6, 2014
Biomarker-driven EGFR therapy improves outcomes in patients with metastatic colorectal cancerAndrew Hendifar, Carlyn-Rose Tan, Anand Annamalai, et al.
Journal of Gastrointestinal Oncology|April 2, 2015
Review of systemic therapies for locally advanced and metastatic rectal cancerPatrick Yaffee, Arsen Osipov, Carlyn Tan, et al.
Oncotarget|October 11, 2024
A case of adenosquamous pancreatic cancer with a KRAS G12C mutation with an exceptional response to immunotherapyMurtaza Ahmed, Brent K Larson, Arsen Osipov, et al.
Translational Gastroenterology and Hepatology|September 28, 2019
Checkpoint inhibition in advanced gastroesophageal cancer: clinical trial data, molecular subtyping, predictive biomarkers, and the potential of combination therapiesJeremy Chuang, Joseph Chao, Andrew Hendifar, et al.
Cancers|November 13, 2021
Advances in Pancreatic Ductal Adenocarcinoma TreatmentEric M Anderson, Shant Thomassian, Jun Gong, et al.
International Journal of Molecular Sciences|July 29, 2020
Molecular Targets, Pathways, and Therapeutic Implications for Hepatocellular CarcinomaJun Gong, Jeremy Chuang, May Cho, et al.
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
The American Journal of Dermatopathology|June 13, 2018
Primary Visceral Merkel Cell Carcinoma: A Case Report and Review of the LiteratureAndrew Siref, Andrew Hendifar, Bonnie Balzer
Drug Design, Development and Therapy|April 20, 2018
Aldoxorubicin: a tumor-targeted doxorubicin conjugate for relapsed or refractory soft tissue sarcomasJun Gong, Jessica Yan, Charles Forscher, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 27, 2018
The use of Ki-67 labeling index to grade pulmonary well-differentiated neuroendocrine neoplasms: current best evidenceAlberto M Marchevsky, Andrew Hendifar, Ann E Walts
Current Oncology Reports|March 19, 2022
Lung Neuroendocrine Tumors: How Does Molecular Profiling Help?Thomas Yang Sun, Andrew Hendifar, Sukhmani K Padda
Expert Review of Anticancer Therapy|June 6, 2014
Biomarker-driven EGFR therapy improves outcomes in patients with metastatic colorectal cancerAndrew Hendifar, Carlyn-Rose Tan, Anand Annamalai, et al.
Journal of Gastrointestinal Oncology|April 2, 2015
Review of systemic therapies for locally advanced and metastatic rectal cancerPatrick Yaffee, Arsen Osipov, Carlyn Tan, et al.
Oncotarget|October 11, 2024
A case of adenosquamous pancreatic cancer with a KRAS G12C mutation with an exceptional response to immunotherapyMurtaza Ahmed, Brent K Larson, Arsen Osipov, et al.
Translational Gastroenterology and Hepatology|September 28, 2019
Checkpoint inhibition in advanced gastroesophageal cancer: clinical trial data, molecular subtyping, predictive biomarkers, and the potential of combination therapiesJeremy Chuang, Joseph Chao, Andrew Hendifar, et al.
Cancers|November 13, 2021
Advances in Pancreatic Ductal Adenocarcinoma TreatmentEric M Anderson, Shant Thomassian, Jun Gong, et al.
International Journal of Molecular Sciences|July 29, 2020
Molecular Targets, Pathways, and Therapeutic Implications for Hepatocellular CarcinomaJun Gong, Jeremy Chuang, May Cho, et al.
Pageof 9